Benefit of Paramedical Care in Accompanying Caregivers of Patients That Had Surgery for an Head and Neck Invasive Cancer

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorCentre Henri Becquerel

About this trial

Head and Neck invasive cancer usually requires surgery that is associated with modifications of the body structure of patient regarding breathing, eating and communication. These modifications are correlated with an important loss of autonomy in patients. During the study, while the patient is hospitalised after the surgery, the paramedical team will train the caregiver of the patient from experimental group a new dimension of autonomy in order to assure a safe return home. The level of learning depends on each caregiver and patient; therefore, an adapted training is provided.

This study evaluates the impact of paramedical care in accompanying caregivers of patients that had surgery for an ENT invasive cancer, by comparing the experimental group (paramedical care) to the standard group (standard care).

The hypothesis of the study is that a benefit will be seen in the experimental group, by reducing the caregiver burden, improving the quality of life of patients and lowering the rate of hospitalisations and prolonged hospitalisations in these patients.

Eligibility criteria

Qualifiers

Age between 18 and 85 years old

ECOG ≤ 2

Patient diagnosed with an head and neck squamous-cell carcinoma, stage T2-T4/N+, non-metastatic, localised at larynx, pharynx, oropharynx, oral cavity or maxillary, needing curative surgery, with indication of radiotherapy after surgery, in accordance to decision of the regular multidisciplinary meetings in cancerology

No ongoing measure of corrective justice for the patient

Disqualifiers

Patient scheduled for surgery after radiotherapy or for surgery on site already irradiated

Patient or caregiver that do not agree to participate in the study (the pair patient-caregiver is needed)

History of psychological or sensorial disorder or anomaly that can prevent the patient from understanding the conditions for study participation

Trial design

Treatments tested in this trial

  • Accompanying caregivers by paramedical team

Treatment groups

76 Participants
are divided into 2 treatment groups

Sponsors and collaborators